Literature DB >> 20067706

Intranasal drug delivery: how, why and what for?

Anaísa Pires1, Ana Fortuna, Gilberto Alves, Amílcar Falcão.   

Abstract

Over the recent decades the interest in intranasal delivery as a non-invasive route for drugs is increased.Since the nasal mucosa offers numerous benefits as a target tissue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. We have, herein, outlined the relevant aspects of nasal anatomy, physiology and histology, and the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation into appropriate nasal pharmaceutical formulations.

Mesh:

Year:  2009        PMID: 20067706     DOI: 10.18433/j3nc79

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  117 in total

1.  Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.

Authors:  Alex Rygg; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2015-12-21       Impact factor: 4.200

2.  High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers.

Authors:  Edward T Maggio; Dennis J Pillion
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

Review 3.  Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Authors:  Clément Mercier; Nathalie Perek; Xavier Delavenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

4.  Pharmacokinetics of a new, nasal formulation of naloxone.

Authors:  Ida Tylleskar; Arne Kristian Skulberg; Turid Nilsen; Sissel Skarra; Phatsawee Jansook; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2017-01-31       Impact factor: 2.953

5.  Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.

Authors:  Claudia Cristiano; Floriana Volpicelli; Pellegrino Lippiello; Benedetta Buono; Federica Raucci; Marialuisa Piccolo; Asif Jilani Iqbal; Carlo Irace; Maria Concetta Miniaci; Carla Perrone Capano; Antonio Calignano; Nicola Mascolo; Francesco Maione
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

Review 6.  Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approval.

Authors:  Bing V Li; Feiyan Jin; Sau L Lee; Tao Bai; Badrul Chowdhury; Hoainhon T Caramenico; Dale P Conner
Journal:  AAPS J       Date:  2013-05-18       Impact factor: 4.009

7.  Electro-physiological changes in the brain induced by caffeine or glucose nasal spray.

Authors:  K De Pauw; B Roelands; J Van Cutsem; U Marusic; T Torbeyns; R Meeusen
Journal:  Psychopharmacology (Berl)       Date:  2016-09-23       Impact factor: 4.530

8.  Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception.

Authors:  Phillip A Saccone; Angela M Lindsey; Robert A Koeppe; Kathy A Zelenock; Xia Shao; Phillip Sherman; Carole A Quesada; James H Woods; Peter J H Scott
Journal:  J Pharmacol Exp Ther       Date:  2016-09-13       Impact factor: 4.030

Review 9.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

10.  Topical Drug Delivery for Chronic Rhinosinusitis.

Authors:  Jonathan Liang; Andrew P Lane
Journal:  Curr Otorhinolaryngol Rep       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.